J Chen, Y Tang, Y Zhong, B Wei, XR Huang… - Molecular Therapy, 2022 - cell.com
Clopidogrel, a P2Y12 inhibitor, is a novel anti-fibrosis agent for chronic kidney disease
(CKD), but its mechanisms remain unclear, which we investigated by silencing P2Y12 or …